VAP % (95% CI) no./total no. | No VAP % (95% CI) no./total no. | Relative risk (95% CI) | P value | |
---|---|---|---|---|
Outcome | ||||
Primary | ||||
ICU mortality | 41.8 (32.6-51.7) 41/98 | 30.7 (25.2-36.8) 74/241 | 1.36 (1.00-1.84) | 0.05 |
Secondary | ||||
28-Day mortality | 26.5 (18.8-36.0) 26/98 | 29.0 (23.7-35.1) 70/241 | 0.91 (0.62-1.34) | 0.64 |
90-Day mortality | 41.8 (32.6-51.7) 41/98 | 33.6 (27.9-39.8) 81/241 | 1.24 (0.93-1.67) | 0.15 |
Ventilator-free days from day 1 to day 28 | 0 (0-10) | 14 (0-21) | 0.0001 | |
Ventilator-free days from day 1 to day 90 | 50.5 (0-70) | 76 (0-83) | 0.0001 | |
ICU-free days from day 1 to day 28 | 0 (0-0) | 4 (0-16) | 0.0001 | |
ICU-free days from day 1 to day 90 | 32 (0-62) | 66 (0-78) | 0.0001 | |
Days without failure of circulatory, coagulation, hepatic, and renal organs from day 1 to day 28 | 14.3 ± 10.4 | 14.0 ± 10.8 | 0.77 |